- Home
- TRSG vs PMN Comparison
TRSG vs PMN Comparison
Compare TRSG & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRSG
- PMN
- Stock Information
- Founded
- TRSG 1996
- PMN 2004
- Country
- TRSG Singapore
- PMN Canada
- Employees
- TRSG N/A
- PMN N/A
- Industry
- TRSG
- PMN Pharmaceuticals and Biotechnology
- Sector
- TRSG
- PMN Health Care
- Exchange
- TRSG NYSE
- PMN Nasdaq
- Market Cap
- TRSG 33.4M
- PMN 29.8M
- IPO Year
- TRSG 2024
- PMN N/A
- Fundamental
- Price
- TRSG $2.00
- PMN $0.96
- Analyst Decision
- TRSG
- PMN
- Analyst Count
- TRSG 0
- PMN 0
- Target Price
- TRSG N/A
- PMN N/A
- AVG Volume (30 Days)
- TRSG 4.6K
- PMN 42.3K
- Earning Date
- TRSG 12-31-2024
- PMN 03-31-2025
- Dividend Yield
- TRSG N/A
- PMN N/A
- EPS Growth
- TRSG N/A
- PMN N/A
- EPS
- TRSG N/A
- PMN N/A
- Revenue
- TRSG $14,441,864.00
- PMN N/A
- Revenue This Year
- TRSG N/A
- PMN N/A
- Revenue Next Year
- TRSG N/A
- PMN N/A
- P/E Ratio
- TRSG N/A
- PMN N/A
- Revenue Growth
- TRSG 9.34
- PMN N/A
- 52 Week Low
- TRSG $1.91
- PMN $0.87
- 52 Week High
- TRSG $11.78
- PMN $2.61
- Technical
- Relative Strength Index (RSI)
- TRSG N/A
- PMN 56.16
- Support Level
- TRSG N/A
- PMN $0.90
- Resistance Level
- TRSG N/A
- PMN $0.95
- Average True Range (ATR)
- TRSG 0.00
- PMN 0.06
- MACD
- TRSG 0.00
- PMN 0.01
- Stochastic Oscillator
- TRSG 0.00
- PMN 67.79
About TRSG TUNGRAY TECHNOLOGIES INC
Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.